This press release was issued by Nelipak® Corporation.
Nelipak® Corporation (“Nelipak”), a leading global provider of healthcare packaging solutions, today announced the opening of its new Asia-Pacific Technical Development Center located in Singapore. This new facility establishes an integrated technical development capability in the Asia-Pacific region combining Nelipak’s flexible and rigid sterile barrier packaging design and innovation capabilities under one roof.
This investment marks a major milestone in Nelipak’s global growth strategy and establishes a permanent technical and innovation presence in one of the world’s fastest-growing medical device innovation and manufacturing hubs. Its strategic location in Singapore offers a launchpad to Asia-Pacific’s medtech and biomedical industries, owing to the country’s strong global connectivity and growing healthcare manufacturing and research capabilities.
The center will enable Nelipak to support customers across Southeast Asia, China, Japan, Korea, India, Australia, and New Zealand. It combines personalized real-time collaboration with Nelipak’s global manufacturing and innovation network to ensure that packaging solutions developed in Asia-Pacific are globally scalable and production-ready.
Designed to enhance how medical device and pharmaceutical companies develop and validate sterile packaging systems, the Asia-Pacific Technical Development Center enables customers to arrive with a medical device concept and leave with a validation ready packaging design and physical samples. For device manufacturers, the benefit is immediate and tangible. Customers can engage directly with Nelipak’s technical experts to co-develop and validate bespoke sterile barrier solutions, streamline iteration cycles and regulatory processes, and accelerate time to market.
The center supports the development of Nelipak’s comprehensive range of custom designed sterile-barrier packaging solutions which integrate both flexible and rigid formats. Its capabilities are also designed to support ISO 11607-compliant development, risk mitigation, and accelerated commercialization for Class I through Class III medical and pharmaceutical devices.
